A class of novel pyrrolo[2,3-d]pyrimidine compounds is disclosed together with the use of such compounds for inhibiting sPLA2 mediated release of fatty acids for treatment of diseases such as septic shock.
Bicyclic sPLA2 inhibitors
申请人:Eli Lilly and Company
公开号:US06384041B1
公开(公告)日:2002-05-07
The compounds are of the class of pyrrolo[2,3-d]pyrimidines useful for inhibiting sPLA2 mediated release of fatty acids for treatment of diseases such as septic shock.